Jeffrey Smith

Jeffrey Smith

Central US Merck & Co., Inc. - Kenilworth / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5696213
-
person_outline Jeffrey Smith's MOST POPULAR ARTICLES
1-) Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infectionAS Espeseth, PJ Cejas, MP Citron, D Wang, DJ DiStefano, C Callahan, ...npj Vaccines 5 (1), 16, 20201372020
2-) A tetravalent sub-unit dengue vaccine formulated with ionizable cationic lipid nanoparticle induces significant immune responses in rodents and non-human primatesG Swaminathan, EA Thoryk, KS Cox, JS Smith, JJ Wolf, ME Gindy, ...Scientific reports 6 (1), 34215, 20161042016
3-) Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA deliveryME Gindy, K DiFelice, V Kumar, RK Prud’homme, R Celano, RM Haas, ...Langmuir 30 (16), 4613-4622, 2014582014
4-) PKA catalytic subunit compartmentation regulates contractile and hypertrophic responses to β-adrenergic signalingJH Yang, RK Polanowska-Grabowska, JS Smith, CW Shields IV, ...Journal of molecular and cellular cardiology 66, 83-93, 2014572014
5-) Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvantsS Awasthi, LM Hook, G Swaminathan, TM Cairns, B Brooks, JS Smith, ...Vaccine 37 (29), 3770-3778, 2019222019